OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+22.49%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$231M
AUM Growth
+$231M
(+6.4%)
Cap. Flow
-$7.34M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$3.03M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.6M |
| 3 |
AKAO
Achaogen, Inc.
AKAO
|
$1.71M |
Sector Composition
| 1 | Healthcare | 58.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $83.4M | 36.07% | 1,375,000 -50,000 | -4% | -$3.03M |
|
|
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $66.9M | 28.91% | 2,138,872 | – | – |
|
|
EGLT
3
DELISTED
Egalet Corporation
EGLT
| $34.2M | 14.79% | 2,645,558 | – | – |
|
4
FibroGen
FGEN
$47.8M
| $30.5M | 13.19% | 972,175 | – | – |
|
|
DRNA
5
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $8.66M | 3.75% | 360,447 -108,024 | -23% | -$2.6M |
|
|
AKAO
6
DELISTED
Achaogen, Inc.
AKAO
| $4.7M | 2.03% | 481,694 -175,205 | -27% | -$1.71M |
|
7
Protara Therapeutics
TARA
$120M
| $2.91M | 1.26% | 250,000 | – | – |
|